Studies of the hypercalcaemia of sarcoidosis: Effect of steroids and exogenous vitamin D3 on the circulating concentrations of 1,25-dihydroxy vitamin D3

L. M. Sandler, C. G. Winearls, L. J. Fraher, Thomas Clemens, R. Smith, J. L. O'Riordan

Research output: Chapter in Book/Report/Conference proceedingChapter

Abstract

Hypercalcemia in 6 patients with sarcoidosis was associated with elevated circulating 1,25-dihydroxy vitamin D3 (187-475 pmol/l): the concentration of this metabolite of vitamin D was a function of the concentration of its precursor, 25-hydroxy vitamin D which remained within the normal range. Corticosteroids, in reducing serum calcium, eliminated this abnormal substrate-product relationship by rapidly reducing circulating 1,25-dihydroxy vitamin D3 while having no effect on 25-hydroxy vitamin D. The fall in circulating 1,25-dihydroxy vitamin D3 preceded the fall of calcium. Studies on the clearance of exogenous 1,25-dihydroxy vitamin D3 indicated that during hypercalcemic episodes, the plasma disappearance time of the sterol was delayed and that this reverted to normal with steroid therapy. Administration of vitamin D3 to these patients with sarcoidosis increased the circulating concentration of 1,25-dihydroxy vitamin D3 and this resulted in hypercalcemia, thus accounting for their hypersensitivity to vitamin D and sunlight.

Original languageEnglish (US)
Title of host publicationQuarterly Journal of Medicine
Pages165-180
Number of pages16
Volume53
Edition210
StatePublished - 1984
Externally publishedYes

Fingerprint

Cholecalciferol
Hypercalcemia
Sarcoidosis
Vitamin D
Steroids
Calcium
Sunlight
Sterols
Adrenal Cortex Hormones
Hypersensitivity
Reference Values
dihydroxy-vitamin D3
Serum

ASJC Scopus subject areas

  • Medicine(all)

Cite this

Sandler, L. M., Winearls, C. G., Fraher, L. J., Clemens, T., Smith, R., & O'Riordan, J. L. (1984). Studies of the hypercalcaemia of sarcoidosis: Effect of steroids and exogenous vitamin D3 on the circulating concentrations of 1,25-dihydroxy vitamin D3. In Quarterly Journal of Medicine (210 ed., Vol. 53, pp. 165-180)

Studies of the hypercalcaemia of sarcoidosis : Effect of steroids and exogenous vitamin D3 on the circulating concentrations of 1,25-dihydroxy vitamin D3. / Sandler, L. M.; Winearls, C. G.; Fraher, L. J.; Clemens, Thomas; Smith, R.; O'Riordan, J. L.

Quarterly Journal of Medicine. Vol. 53 210. ed. 1984. p. 165-180.

Research output: Chapter in Book/Report/Conference proceedingChapter

Sandler, LM, Winearls, CG, Fraher, LJ, Clemens, T, Smith, R & O'Riordan, JL 1984, Studies of the hypercalcaemia of sarcoidosis: Effect of steroids and exogenous vitamin D3 on the circulating concentrations of 1,25-dihydroxy vitamin D3. in Quarterly Journal of Medicine. 210 edn, vol. 53, pp. 165-180.
Sandler LM, Winearls CG, Fraher LJ, Clemens T, Smith R, O'Riordan JL. Studies of the hypercalcaemia of sarcoidosis: Effect of steroids and exogenous vitamin D3 on the circulating concentrations of 1,25-dihydroxy vitamin D3. In Quarterly Journal of Medicine. 210 ed. Vol. 53. 1984. p. 165-180
Sandler, L. M. ; Winearls, C. G. ; Fraher, L. J. ; Clemens, Thomas ; Smith, R. ; O'Riordan, J. L. / Studies of the hypercalcaemia of sarcoidosis : Effect of steroids and exogenous vitamin D3 on the circulating concentrations of 1,25-dihydroxy vitamin D3. Quarterly Journal of Medicine. Vol. 53 210. ed. 1984. pp. 165-180
@inbook{50ff9cd9137e436c87561dc0f96c7b68,
title = "Studies of the hypercalcaemia of sarcoidosis: Effect of steroids and exogenous vitamin D3 on the circulating concentrations of 1,25-dihydroxy vitamin D3",
abstract = "Hypercalcemia in 6 patients with sarcoidosis was associated with elevated circulating 1,25-dihydroxy vitamin D3 (187-475 pmol/l): the concentration of this metabolite of vitamin D was a function of the concentration of its precursor, 25-hydroxy vitamin D which remained within the normal range. Corticosteroids, in reducing serum calcium, eliminated this abnormal substrate-product relationship by rapidly reducing circulating 1,25-dihydroxy vitamin D3 while having no effect on 25-hydroxy vitamin D. The fall in circulating 1,25-dihydroxy vitamin D3 preceded the fall of calcium. Studies on the clearance of exogenous 1,25-dihydroxy vitamin D3 indicated that during hypercalcemic episodes, the plasma disappearance time of the sterol was delayed and that this reverted to normal with steroid therapy. Administration of vitamin D3 to these patients with sarcoidosis increased the circulating concentration of 1,25-dihydroxy vitamin D3 and this resulted in hypercalcemia, thus accounting for their hypersensitivity to vitamin D and sunlight.",
author = "Sandler, {L. M.} and Winearls, {C. G.} and Fraher, {L. J.} and Thomas Clemens and R. Smith and O'Riordan, {J. L.}",
year = "1984",
language = "English (US)",
volume = "53",
pages = "165--180",
booktitle = "Quarterly Journal of Medicine",
edition = "210",

}

TY - CHAP

T1 - Studies of the hypercalcaemia of sarcoidosis

T2 - Effect of steroids and exogenous vitamin D3 on the circulating concentrations of 1,25-dihydroxy vitamin D3

AU - Sandler, L. M.

AU - Winearls, C. G.

AU - Fraher, L. J.

AU - Clemens, Thomas

AU - Smith, R.

AU - O'Riordan, J. L.

PY - 1984

Y1 - 1984

N2 - Hypercalcemia in 6 patients with sarcoidosis was associated with elevated circulating 1,25-dihydroxy vitamin D3 (187-475 pmol/l): the concentration of this metabolite of vitamin D was a function of the concentration of its precursor, 25-hydroxy vitamin D which remained within the normal range. Corticosteroids, in reducing serum calcium, eliminated this abnormal substrate-product relationship by rapidly reducing circulating 1,25-dihydroxy vitamin D3 while having no effect on 25-hydroxy vitamin D. The fall in circulating 1,25-dihydroxy vitamin D3 preceded the fall of calcium. Studies on the clearance of exogenous 1,25-dihydroxy vitamin D3 indicated that during hypercalcemic episodes, the plasma disappearance time of the sterol was delayed and that this reverted to normal with steroid therapy. Administration of vitamin D3 to these patients with sarcoidosis increased the circulating concentration of 1,25-dihydroxy vitamin D3 and this resulted in hypercalcemia, thus accounting for their hypersensitivity to vitamin D and sunlight.

AB - Hypercalcemia in 6 patients with sarcoidosis was associated with elevated circulating 1,25-dihydroxy vitamin D3 (187-475 pmol/l): the concentration of this metabolite of vitamin D was a function of the concentration of its precursor, 25-hydroxy vitamin D which remained within the normal range. Corticosteroids, in reducing serum calcium, eliminated this abnormal substrate-product relationship by rapidly reducing circulating 1,25-dihydroxy vitamin D3 while having no effect on 25-hydroxy vitamin D. The fall in circulating 1,25-dihydroxy vitamin D3 preceded the fall of calcium. Studies on the clearance of exogenous 1,25-dihydroxy vitamin D3 indicated that during hypercalcemic episodes, the plasma disappearance time of the sterol was delayed and that this reverted to normal with steroid therapy. Administration of vitamin D3 to these patients with sarcoidosis increased the circulating concentration of 1,25-dihydroxy vitamin D3 and this resulted in hypercalcemia, thus accounting for their hypersensitivity to vitamin D and sunlight.

UR - http://www.scopus.com/inward/record.url?scp=0021222637&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0021222637&partnerID=8YFLogxK

M3 - Chapter

C2 - 6087399

AN - SCOPUS:0021222637

VL - 53

SP - 165

EP - 180

BT - Quarterly Journal of Medicine

ER -